Oncolytic Virotherapy versus Cancer Stem Cells: A Review of Approaches and Mechanisms
A growing body of evidence suggests that a subset of cells within tumors are resistant to conventional treatment modalities and may be responsible for disease recurrence. These cells are called cancer stem cells (CSC), which share properties with normal stem cells including self-renewal, pluripotenc...
Main Authors: | Shyambabu Chaurasiya, Nanhai G. Chen, Susanne G. Warner |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/10/4/124 |
Similar Items
-
Oncolytic Virotherapy for Cancer: Clinical Experience
by: Shyambabu Chaurasiya, et al.
Published: (2021-04-01) -
Viroimmunotherapy for Colorectal Cancer: Clinical Studies
by: Shyambabu Chaurasiya, et al.
Published: (2017-03-01) -
From Benchtop to Bedside: A Review of Oncolytic Virotherapy
by: Audrey H. Choi, et al.
Published: (2016-08-01) -
Prospects for Using Expression Patterns of Paramyxovirus Receptors as Biomarkers for Oncolytic Virotherapy
by: Olga V. Matveeva, et al.
Published: (2020-12-01) -
Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy
by: Valentina Marchica, et al.
Published: (2020-07-01)